PRO/AH/EDR> Tuberculosis, XDR: pretomanid, 6-mo 3-drug oral regimen, FDA approved

Tuberculosis -- Worldwide/Unknown
The trial [a South African patient] joined was small -- it enrolled only 109 patients -- but experts are calling the preliminary results groundbreaking. The drug regimen tested on [her] has shown a 90% success rate against a deadly plague, extensively drug-resistant tuberculosis.
On Wednesday [14 Aug 2019], the Food and Drug Administration (FDA) effectively endorsed the approach, approving the newest of the 3 drugs used in the regimen. Usually, the World Health Organization adopts approvals

Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?6626411&promed&0